GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYRY) » Definitions » Enterprise Value

Bayer AG (Bayer AG) Enterprise Value : $63,169 Mil (As of Apr. 25, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Bayer AG Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bayer AG's Enterprise Value is $63,169 Mil. Bayer AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $490 Mil. Therefore, Bayer AG's EV-to-EBIT ratio for today is 128.87.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Bayer AG's Enterprise Value is $63,169 Mil. Bayer AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $11,251 Mil. Therefore, Bayer AG's EV-to-EBITDA ratio for today is 5.61.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Bayer AG's Enterprise Value is $63,169 Mil. Bayer AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $51,344 Mil. Therefore, Bayer AG's EV-to-Revenue ratio for today is 1.23.


Bayer AG Enterprise Value Historical Data

The historical data trend for Bayer AG's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Enterprise Value Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 117,092.09 94,601.42 88,198.22 83,713.91 71,645.18

Bayer AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83,713.91 54,225.39 46,232.62 37,402.93 71,645.18

Competitive Comparison of Bayer AG's Enterprise Value

For the Drug Manufacturers - General subindustry, Bayer AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Bayer AG's Enterprise Value falls into.



Bayer AG Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Bayer AG's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Bayer AG's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bayer AG  (OTCPK:BAYRY) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Bayer AG's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=63169.309/490.186
=128.87

Bayer AG's current Enterprise Value is $63,169 Mil.
Bayer AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $490 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Bayer AG's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=63169.309/11251.279
=5.61

Bayer AG's current Enterprise Value is $63,169 Mil.
Bayer AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $11,251 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Bayer AG's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=63169.309/51344.125
=1.23

Bayer AG's current Enterprise Value is $63,169 Mil.
Bayer AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $51,344 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bayer AG Enterprise Value Related Terms

Thank you for viewing the detailed overview of Bayer AG's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (Bayer AG) Business Description

Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.